The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis

• Published in: European journal of cancer (1990) 2020-06, Vol.132, p.71-84
• Main Authors: Orhan, Adile, Vogelsang, Rasmus P., Andersen, Malene B., Madsen, Michael T., Hölmich, Emma R., Raskov, Hans, Gögenur, Ismail
• Format: Article
• Language: English
• Subjects: Cancer; CD3 antigen; CD4 antigen; CD8 antigen; Colorectal carcinoma; Confidence intervals; Cytotoxicity; Foxp3 protein; Frequency analysis; Immune checkpoint inhibitors; Immune infiltration; Immune system; Impact analysis; Infiltration; Invasiveness; Literature reviews; Localization; Lymphocytes; Lymphocytes T; Medical prognosis; Meta-analysis; Metastases; Overall survival; Pancreatic cancer; Phenotypes; Prognosis; Quality; Stroma; Subgroups; Survival; Systematic review; Tumors; Tumour-infiltrating lymphocytes
• ISSN: 0959-8049; 1879-0852
• DOI: 10.1016/j.ejca.2020.03.013

Tumour-infiltrating lymphocytes (TILs) have previously been found to influence patient prognosis in other gastrointestinal cancers, for instance in colorectal cancer. An immunosuppressive phenotype often characterizes pancreatic cancer with a low degree of immune cell infiltration. Cytotoxic CD8+ T cell infiltration in tumours is found to be the best predictive variable for response to immune checkpoint inhibitor therapy, emphasizing the importance of investigating TILs in pancreatic cancer, especially focussing on CD8+ T cells. Here, we systematically review the literature and perform meta-analyses to examine the prognostic value of TILs in human pancreatic ductal adenocarcinomas (PDAC). Secondarily, we review the literature regarding the histological localization of TILs and the impact on survival in PDAC. A literature search was conducted on PubMed, Embase, The Cochrane Library and Web of Science. Studies examining patients with PDAC and the impact of high vs. low infiltration of immune cells on long-term oncological survival measures were included. Time-to-event meta-analysis and frequency analysis were conducted using a random effects model. The risk of bias was assessed using the Newcastle-Ottowa Scale. Quality of the cumulative evidence was evaluated using the GRADE approach for prognostic studies. In total, 1971 articles were screened, of which 43 studies were included in the systematic review and 39 in the meta-analysis. High infiltration of CD8+ lymphocytes was significantly associated with improved overall survival (OS) [hazard ratio (HR) = 0.58, 95% confidence intervals (CIs): 0.50–0.68], disease-free survival (DFS) [HR = 0.64, 95% CI: 0.52–0.78], progression-free survival [HR = 0.66, 95% CI: 0.51–0.86] and cancer-specific survival [HR = 0.56, 95% CI: 0.32–0.99]. A high infiltration of CD3+ T cells was correlated with increased OS [HR = 0.58, 95% CI: 0.50–0.68] and DFS [HR = 0.74, 95% CI: 0.38–1.43]. Infiltration of CD4+ lymphocytes was associated with improved 12-months OS [risk ratio = 0.59, 95% CI: 0.35–0.99] and DFS [risk ratio = 0.68, 95% CI: 0.53–0.88]. High expression of FoxP3+ lymphocytes was associated with poor OS [HR = 1.48, 95% CI: 1.20–1.83]. The greatest impact on survival was observed in the CD8+ T cell and OS group, when infiltration was located to the tumour centre [HR = 0.53, 95% CI: 0.45–0.63]. However, subgroup analysis on the impact of the histological location of infiltration revealed no significant differences between the